Camber is excited to announce the introduction of 8 new generic products to our growing portfolio during the third quarter of this year. These launches mark a significant step forward in our ongoing mission to provide patients and healthcare providers with high-quality, cost-effective alternatives to brand-name medications. The new products in our portfolio include:
- Lidocaine HCl Injection 1% & 2% generic for Xylocaine® – commonly used as a local anesthetic for surgical and procedural pain management.
- Quetiapine Fumarate Tablets generic for Seroquel® – an antipsychotic medication used to treat schizophrenia, bipolar disorder, and major depressive disorder.
- Gabapentin Oral Solution generic for Neurontin® – used to manage seizures and neuropathic pain.
- Ivabradine Tablets generic for Corlanor® – prescribed for heart rate management in patients with certain types of chronic heart failure.
- Diatrizoate Meglumine & Diatrizoate Sodium generic for Gastrografin® – a diagnostic contrast agent used in radiographic imaging to enhance visibility during X-rays.
- Dabigatran Capsules generic for Pradaxa® – a blood thinner used to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation.
- Capecitabine Tablets generic for Xeloda® – an oral chemotherapy drug used in the treatment of breast, colon, and colorectal cancers.
- Decitabine for Injection generic for Dacogen® – an injectable chemotherapy treatment for certain forms of blood cancers, including myelodysplastic syndromes (MDS).
These innovative products are key additions to our portfolio. Earlier this year, Camber made significant strides with the successful launch of several other essential generics during Q1 and Q2, including:
- Levonorgestrel and Ethinyl Estradiol Tablets generic for Alesse® – a combination oral contraceptive.
- Theophylline ER Tablets generic for Theophylline® ER – used in managing asthma and chronic obstructive pulmonary disease (COPD).
- Allopurinol Tablets generic for Zyloprim® – prescribed for treating gout and high uric acid levels.
- Gabapentin Tablets generic for Gralise® – for postherpetic neuralgia and epilepsy.
- Fesoterodine Fumarate ER Tablets generic for Toviaz® – managing overactive bladder symptoms.
- Aripiprazole Oral Solutiongeneric for Abilify® – for the treatment of schizophrenia, bipolar disorder, and irritability associated with autism.
- Pantoprazole Sodium DR for Oral Suspension generic for Protonix® – for gastroesophageal reflux disease (GERD) and related conditions.
- Rufinamide Oral Suspension generic for Banzel® – a medication used to control seizures in patients with Lennox-Gastaut syndrome.
- Mesalamine DR Tablets generic for Lialda® – treating inflammatory bowel diseases, including ulcerative colitis.
- Pitavastatin Tablets generic for Livalo® – used to lower cholesterol and triglyceride levels.
In addition to our new product introductions, Camber has responded to market demand by relaunching several key generics. These products have been reintroduced to ensure consistent supply for our healthcare partners and to meet the ongoing needs of patients:
- Tolterodine ER Capsules generic for Detrol® LA – used to treat overactive bladder symptoms.
- Gabapentin Capsules generic for Neurontin® – for seizure control and neuropathic pain relief.
- Duloxetine DR Capsules generic for Cymbalta® – for treating depression, anxiety, and chronic pain conditions.
- Metoprolol ER Tablets generic for Toprol® XL – for managing high blood pressure, angina, and heart failure.
- Atorvastatin Tablets generic for Lipitor® – to lower cholesterol and reduce the risk of heart attack and stroke.
- Ezetimibe generic for Zetia® – to help reduce cholesterol levels in the blood.
Our vertically integrated approach enables us to offer a broad range of high-quality generic pharmaceuticals, making vital treatments more accessible to patients and healthcare providers alike. For more information on our recent product launches or to explore our full product offerings, please contact your Camber representative.
